Literature DB >> 15781263

A new human gene hNTKL-BP1 interacts with hPirh2.

Liping Zhang1, Jinjun Li, Chunyan Wang, Yating Ma, Keke Huo.   

Abstract

NTKL (N-terminal kinase-like protein) encodes an evolutionarily conserved kinase-like protein and is mapped around chromosomal breakpoints found in several carcinomas, suggesting that NTKL dysfunction may be involved in carcinogenesis. Recently, we identified a novel mouse gene, mNTKL-BP1 (NTKL-binding protein 1), encoding a protein interacting with NTKL. For further study, a new human gene, hNTKL-BP1, which is highly homologous with mNTKL-BP1, was used as bait in yeast two-hybrid system. hPirh2 (human p53-induced RING-H2 protein) was identified as hNTKL-BP1 interacting protein. The specific interaction of two proteins was confirmed by pull-down assay in vitro and co-immunoprecipitation in vivo. Moreover, an immunofluorescent staining assay showed that hNTKL-BP1 colocalizes with hPirh2 in SMMC 7721 cells. It will stimulate further investigation into whether hNTKL-BP1 is the substrate of hPirh2 or interaction of hNTKL-BP1 with hPirh2 enhances or represses the ubiquitin-protein ligase activity of hPirh2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781263     DOI: 10.1016/j.bbrc.2005.02.156

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  GORAB Missense Mutations Disrupt RAB6 and ARF5 Binding and Golgi Targeting.

Authors:  Johannes Egerer; Denise Emmerich; Björn Fischer-Zirnsak; Wing Lee Chan; David Meierhofer; Beyhan Tuysuz; Katrin Marschner; Sascha Sauer; Francis A Barr; Stefan Mundlos; Uwe Kornak
Journal:  J Invest Dermatol       Date:  2015-05-22       Impact factor: 8.551

2.  A newly identified Pirh2 substrate SCYL1-BP1 can bind to MDM2 and accelerate MDM2 self-ubiquitination.

Authors:  Jing Yan; Di Zhang; Yujun Di; Huili Shi; Hai Rao; Keke Huo
Journal:  FEBS Lett       Date:  2010-06-23       Impact factor: 4.124

3.  Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination.

Authors:  Jing Yan; Yujun Di; Huili Shi; Hai Rao; Keke Huo
Journal:  FEBS Lett       Date:  2010-09-17       Impact factor: 4.124

Review 4.  Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  FEBS Lett       Date:  2012-04-03       Impact factor: 4.124

5.  SCY1-Like 1-Binding Protein 1 (SCYL1BP1) Suppressed Sciatic Nerve Regeneration by Enhancing the RhoA Pathway.

Authors:  Weidong Zhang; Yonghua Liu; Xudong Zhu; Yi Cao; Yang Liu; Xingxing Mao; Huiguang Yang; Zhengming Zhou; Youhua Wang; Aiguo Shen
Journal:  Mol Neurobiol       Date:  2015-11-16       Impact factor: 5.590

6.  Impact of siRNA targeting pirh2 on proliferation and cell cycle control of the lung adenocarcinoma cell line A549.

Authors:  Yuan Su; Liping Zhu; Yang Jin; Xiaoju Zhang; Qiong Zhou; Ming Bai
Journal:  Front Med China       Date:  2007-10-01

7.  Different functions of HIPK2 and CtBP2 in traumatic brain injury.

Authors:  Feihui Zou; Jian Xu; Hongran Fu; Jianhua Cao; Hui Mao; Mingjie Gong; Gang Cui; Yang Zhang; Wei Shi; Jian Chen
Journal:  J Mol Neurosci       Date:  2012-10-18       Impact factor: 3.444

8.  SCY1-like 1 binding protein 1 (SCYL1-bp1) interacts with p53-induced RING H2 protein (Pirh2) after traumatic brain injury in rats.

Authors:  Jian Chen; Feihui Zou; Hongran Fu; Hui Mao; Mingjie Gong; Lanchun Ni; Xide Xu; Jinlong Shi; Kaifu Ke; Maohong Cao; Fei Zhou; Wei Shi
Journal:  J Mol Histol       Date:  2013-03-12       Impact factor: 2.611

9.  Ubiquitylation of epsilon-COP by PIRH2 and regulation of the secretion of PSA.

Authors:  Satoru Maruyama; Naoto Miyajima; Miyuki Bohgaki; Tadasuke Tsukiyama; Masahiko Shigemura; Katsuya Nonomura; Shigetsugu Hatakeyama
Journal:  Mol Cell Biochem       Date:  2007-08-25       Impact factor: 3.396

10.  SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway.

Authors:  Yonghua Liu; Ying Chen; Xiang Lu; Youhua Wang; Yinong Duan; Chun Cheng; Aiguo Shen
Journal:  Mol Biol Cell       Date:  2012-10-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.